Rosuvastatin in African Americans With Cerebrovascular Disease

• Status: Terminated
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will assess the rate at which rosuvastatin will achieve LDL targets in African American patients with previous history of stroke or TIA.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wayne State University
• Treatments: Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Age 30 and above

• Rankin score of ≤ 3

• Patient has a fixed telephone number and is available for follow-up

• African American

• Diagnosis of ischemic stroke or TIA in past 12 months

Exclusion Criteria:

• Liver enzyme abnormalities (ALT or AST >2x ULN)

• Known muscle disorder or CK > 5x ULN

• Alcoholism or substance abuse

• Stroke due to dissection or hypercoagulable state

• Moderate to severe dementia (MMSE <20)

• On hemodialysis

• No fixed home address